Haloperidol
0099640
Ordering Recommendation
 
Mnemonic
HALO
Methodology
Quantitative Liquid Chromatography-Tandem Mass Spectrometry
Performed
Mon, Wed, Fri
Reported
1-5 days  
New York DOH Approval Status
This test is New York DOH approved.
Submit With Order
Specimen Required
Patient Preparation
Timing of specimen collection: Pre-dose (trough) draw - At steady state concentration.  
Collect
Plain red. Also acceptable: Lavender (K2 or K3EDTA) or pink (K2EDTA).
   
Specimen Preparation
Separate serum or plasma from cells within 2 hours of collection. Transfer 1 mL serum or plasma to an ARUP Standard Transport Tube. (Min: 0.5 mL)  
Storage/Transport Temperature
Refrigerated.  
Unacceptable Conditions
Whole blood. Gel separator tubes, light blue (citrate), or yellow (SPS or ACD solution).  
Remarks
  
Stability
After separation from cells: Ambient: 4 hours; Refrigerated: 1 week; Frozen: 1 month (avoid repeated freeze/thaw cycles)  
Reference Interval
Effective November 18, 2013
 
Therapeutic Range: 5.0-​20.0 ng/mL
Toxic: Greater than 42 ng/mL
Interpretive Data
Adverse effects may include drowsiness, blurred vision, tardive dyskinesia, tachycardia, nausea and vomiting.  
Note
 
CPT Code(s)
80173
Components
Component Test Code*Component Chart NameLOINC
0099640Haloperidol3669-9
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.
Aliases
  • Haldol